These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29739922)

  • 1. Bordetella pertussis isolates vary in their interactions with human complement components.
    Brookes C; Freire-Martin I; Cavell B; Alexander F; Taylor S; Persaud R; Fry N; Preston A; Diavatopoulos D; Gorringe A
    Emerg Microbes Infect; 2018 May; 7(1):81. PubMed ID: 29739922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement evasion by Bordetella pertussis: implications for improving current vaccines.
    Jongerius I; Schuijt TJ; Mooi FR; Pinelli E
    J Mol Med (Berl); 2015 Apr; 93(4):395-402. PubMed ID: 25686752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquisition of C1 inhibitor by Bordetella pertussis virulence associated gene 8 results in C2 and C4 consumption away from the bacterial surface.
    Hovingh ES; van den Broek B; Kuipers B; Pinelli E; Rooijakkers SHM; Jongerius I
    PLoS Pathog; 2017 Jul; 13(7):e1006531. PubMed ID: 28742139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virulence Associated Gene 8 of
    Hovingh ES; de Maat S; Cloherty APM; Johnson S; Pinelli E; Maas C; Jongerius I
    Front Immunol; 2018; 9():1172. PubMed ID: 29915576
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of the minimum region of Bordetella pertussis Vag8 required for interaction with C1 inhibitor.
    Onoda N; Hiramatsu Y; Teruya S; Suzuki K; Horiguchi Y
    Microbiol Immunol; 2020 Aug; 64(8):570-573. PubMed ID: 32396237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diversion of complement-mediated killing by Bordetella.
    Thiriard A; Raze D; Locht C
    Microbes Infect; 2018; 20(9-10):512-520. PubMed ID: 29454132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bordetella pertussis binds human C1 esterase inhibitor during the virulent phase, to evade complement-mediated killing.
    Marr N; Luu RA; Fernandez RC
    J Infect Dis; 2007 Feb; 195(4):585-8. PubMed ID: 17230419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of (antibody-dependent) complement-mediated serum killing in protection against Bordetella pertussis.
    Geurtsen J; Fae KC; van den Dobbelsteen GP
    Expert Rev Vaccines; 2014 Oct; 13(10):1229-40. PubMed ID: 25081731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Basis for Bordetella pertussis Interference with Complement, Coagulation, Fibrinolytic, and Contact Activation Systems: the Cryo-EM Structure of the Vag8-C1 Inhibitor Complex.
    Dhillon A; Deme JC; Furlong E; Roem D; Jongerius I; Johnson S; Lea SM
    mBio; 2021 Mar; 12(2):. PubMed ID: 33758081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bordetella pertussis isolates in Finland: serotype and fimbrial expression.
    Heikkinen E; Xing DK; Olander RM; Hytönen J; Viljanen MK; Mertsola J; He Q
    BMC Microbiol; 2008 Sep; 8():162. PubMed ID: 18816412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Bordetella pertussis Bps polysaccharide enhances lung colonization by conferring protection from complement-mediated killing.
    Ganguly T; Johnson JB; Kock ND; Parks GD; Deora R
    Cell Microbiol; 2014 Jul; 16(7):1105-18. PubMed ID: 24438122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pertussis: a matter of immune modulation.
    de Gouw D; Diavatopoulos DA; Bootsma HJ; Hermans PW; Mooi FR
    FEMS Microbiol Rev; 2011 May; 35(3):441-74. PubMed ID: 21204863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between Bordetella pertussis and the complement inhibitor factor H.
    Amdahl H; Jarva H; Haanperä M; Mertsola J; He Q; Jokiranta TS; Meri S
    Mol Immunol; 2011 Jan; 48(4):697-705. PubMed ID: 21167605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bordetella pertussis strain variation and evolution postvaccination.
    Kallonen T; He Q
    Expert Rev Vaccines; 2009 Jul; 8(7):863-75. PubMed ID: 19538113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the complement cascade by Bordetella pertussis.
    Barnes MG; Weiss AA
    FEMS Microbiol Lett; 2003 Mar; 220(2):271-5. PubMed ID: 12670691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bordetella pertussis autotransporter Vag8 binds human C1 esterase inhibitor and confers serum resistance.
    Marr N; Shah NR; Lee R; Kim EJ; Fernandez RC
    PLoS One; 2011; 6(6):e20585. PubMed ID: 21695123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum reactome induced by Bordetella pertussis infection and Pertussis vaccines: qualitative differences in serum antibody recognition patterns revealed by peptide microarray analysis.
    Valentini D; Ferrara G; Advani R; Hallander HO; Maeurer MJ
    BMC Immunol; 2015 Jul; 16():40. PubMed ID: 26129684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model.
    Saito M; Odanaka K; Otsuka N; Kamachi K; Watanabe M
    Microbiol Immunol; 2016 Sep; 60(9):599-608. PubMed ID: 27515393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of in vivo-expressed autotransporters against Bordetella pertussis infection.
    Suzuki K; Shinzawa N; Ishigaki K; Nakamura K; Abe H; Fukui-Miyazaki A; Ikuta K; Horiguchi Y
    Microbiol Immunol; 2017 Sep; 61(9):371-379. PubMed ID: 28752940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough].
    Rastawicki W; Smietańska K; Rokosz-Chudziak N; Jagielski M
    Med Dosw Mikrobiol; 2013; 65(4):269-74. PubMed ID: 24730215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.